<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28621733</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>19</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-3049</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Jun</Month><Day>16</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>Discovery of Indeno[1,2-c]quinoline Derivatives as Potent Dual Antituberculosis and Anti-Inflammatory Agents.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1001</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules22061001</ELocationID><Abstract><AbstractText>A series of indeno[1,2-<i>c</i>]quinoline derivatives were designed, synthesized and evaluated for their anti-tuberculosis (anti-TB) and anti-inflammatory activities. The minimum inhibitory concentration (MIC) of the newly synthesized compound was tested against <i>Mycobacterium tuberculosis</i> H<sub>37</sub>R<sub>V</sub>. Among the tested compounds, (<i>E</i>)-<i>N</i>'-[6-(4-hydroxypiperidin-1-yl)-11<i>H</i>-indeno[1,2-<i>c</i>]quinolin-11-ylidene]isonicotino-hydrazide (<b>12</b>), exhibited significant activities against the growth of <i>M. tuberculosis</i> (MIC values of 0.96 &#x3bc;g/mL) with a potency approximately equal to that of isoniazid (INH), an anti-TB drug. Important structure features were analyzed by quantitative structure-activity relationship (QSAR) analysis to give better insights into the structure determinants for predicting the anti-TB activity. The anti-inflammatory activity was induced by superoxide anion generation and neutrophil elastase (NE) release using the formyl-l-methionyl-l-leucyl-l-phenylalanine (fMLF)-activated human neutrophils method. Results indicated that compound <b>12</b> demonstrated a potent dual inhibitory effect on NE release and superoxide anion generation with IC<sub>50</sub> values of 1.76 and 1.72 &#x3bc;M, respectively. Our results indicated that compound <b>12</b> is a potential lead compound for the discovery of dual anti-TB and anti-inflammatory drug candidates. In addition, 6-[3-(hydroxymethyl)piperidin-1-yl]-9-methoxy-11<i>H</i>-indeno[1,2-<i>c</i>]quinolin-11-one (<b>4g</b>) showed a potent dual inhibitory effect on NE release and superoxide anion generation with IC<sub>50</sub> values of 0.46 and 0.68 &#x3bc;M, respectively, and is a potential lead compound for the discovery of anti-inflammatory drug candidates.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tseng</LastName><ForeName>Chih-Hua</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan. chihhua@kmu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan. chihhua@kmu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Natural Products and Drug Development, Kaohsiung Medical University, Kaohsiung 807, Taiwan. chihhua@kmu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung 807, Taiwan. chihhua@kmu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Research, Kaohsiung Medical University-Hospital, Kaohsiung 807, Taiwan. chihhua@kmu.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tung</LastName><ForeName>Chun-Wei</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan. cwtung@kmu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Research, Kaohsiung Medical University-Hospital, Kaohsiung 807, Taiwan. cwtung@kmu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ph.D. Program in Toxicology, Kaohsiung Medical University, Kaohsiung City 807, Taiwan. cwtung@kmu.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Chen-Hsin</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Medicinal and Applied Chemistry, College of Life Science, Kaohsiung Medical University, Kaohsiung 807, Taiwan. creator770326@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tzeng</LastName><ForeName>Cherng-Chyi</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Research Center for Natural Products and Drug Development, Kaohsiung Medical University, Kaohsiung 807, Taiwan. tzengch@kmu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Research, Kaohsiung Medical University-Hospital, Kaohsiung 807, Taiwan. tzengch@kmu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicinal and Applied Chemistry, College of Life Science, Kaohsiung Medical University, Kaohsiung 807, Taiwan. tzengch@kmu.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yen-Hsu</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University-Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan. infchen@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan. infchen@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Kaohsiung Medical University-Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan. infchen@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Dengue Fever Control and Research, Kaohsiung Medical University, Kaohsiung 807, Taiwan. infchen@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Tsong-Long</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Graduate Institute of Natural Products, College of Medicine, and Chinese Herbal Medicine Research Team, Healthy Aging Research Center, Chang Gung University, Taoyuan 333, Taiwan. htl@mail.cgu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Chinese Herbal Medicine, Research Center for Food and Cosmetic Safety, and Graduate Institute of Health Industry Technology, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan 333, Taiwan. htl@mail.cgu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan. htl@mail.cgu.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yeh-Long</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung 807, Taiwan. yeloch@kmu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Research, Kaohsiung Medical University-Hospital, Kaohsiung 807, Taiwan. yeloch@kmu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicinal and Applied Chemistry, College of Life Science, Kaohsiung Medical University, Kaohsiung 807, Taiwan. yeloch@kmu.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000995">Antitubercular Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011804">Quinolines</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.21.37</RegistryNumber><NameOfSubstance UI="D019272">Leukocyte Elastase</NameOfSubstance></Chemical><Chemical><RegistryNumber>V83O1VOZ8L</RegistryNumber><NameOfSubstance UI="D007538">Isoniazid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000995" MajorTopicYN="N">Antitubercular Agents</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007538" MajorTopicYN="N">Isoniazid</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019272" MajorTopicYN="N">Leukocyte Elastase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009169" MajorTopicYN="N">Mycobacterium tuberculosis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021281" MajorTopicYN="N">Quantitative Structure-Activity Relationship</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011804" MajorTopicYN="N">Quinolines</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anti-inflammatory activity</Keyword><Keyword MajorTopicYN="N">antimycobacterial activity</Keyword><Keyword MajorTopicYN="N">indeno[1,2-c]quinoline</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28621733</ArticleId><ArticleId IdType="pmc">PMC6152673</ArticleId><ArticleId IdType="doi">10.3390/molecules22061001</ArticleId><ArticleId IdType="pii">molecules22061001</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Scott H.M., Flynn J.L. Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: Influence of dose on disease progression. Infect. Immun. 2002;70:5946&#x2013;5954. doi: 10.1128/IAI.70.11.5946-5954.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.70.11.5946-5954.2002</ArticleId><ArticleId IdType="pmc">PMC130313</ArticleId><ArticleId IdType="pubmed">12379669</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters W., Scott H.M., Chambers H.F., Flynn J.L., Charo I.F., Ernst J.D. Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA. 2001;98:7958&#x2013;7963. doi: 10.1073/pnas.131207398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.131207398</ArticleId><ArticleId IdType="pmc">PMC35450</ArticleId><ArticleId IdType="pubmed">11438742</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Garra A., Redford P.S., McNab F.W., Bloom C.I., Wilkinson R.J., Berry M.P.R. The immune response in tuberculosis. Annu. Rev. Immunol. 2013;31:475&#x2013;527. doi: 10.1146/annurev-immunol-032712-095939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-032712-095939</ArticleId><ArticleId IdType="pubmed">23516984</ArticleId></ArticleIdList></Reference><Reference><Citation>Dooley D.P., Carpenter J.L., Rademacher S. Adjunctive corticosteroid therapy for tuberculosis: A critical reappraisal of the literature. Clin. Infect. Dis. 1997;25:872&#x2013;887. doi: 10.1086/515543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/515543</ArticleId><ArticleId IdType="pubmed">9356803</ArticleId></ArticleIdList></Reference><Reference><Citation>Worthington R.J., Melander C. Combination approaches to combat multi-drug-resistant bacteria. Trends Biotechnol. 2013;31:177&#x2013;184. doi: 10.1016/j.tibtech.2012.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibtech.2012.12.006</ArticleId><ArticleId IdType="pmc">PMC3594660</ArticleId><ArticleId IdType="pubmed">23333434</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallis R.S., Maeurer M., Mwaba P., Chakaya J., Rustomjee R., Migliori G.B., Marais B., Schito M., Churchyard G., Swaminathan S., et al. Tuberculosis&#x2014;Advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers. Lancet Infect. Dis. 2016;16:e34&#x2013;e46. doi: 10.1016/S1473-3099(16)00070-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(16)00070-0</ArticleId><ArticleId IdType="pubmed">27036358</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayasam G.V., Balganesh T.S. Exploring the potential of adjunct therapy in tuberculosis. Trends Pharmacol. Sci. 2015;36:506&#x2013;513. doi: 10.1016/j.tips.2015.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2015.05.005</ArticleId><ArticleId IdType="pubmed">26073420</ArticleId></ArticleIdList></Reference><Reference><Citation>Cholo M.C., Steel H.C., Fourie P.B., Germishuizen W.A., Anderson R. Clofazimine: Current status and future prospects. J. Antimicrob. Chemother. 2012;67:290&#x2013;298. doi: 10.1093/jac/dkr444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkr444</ArticleId><ArticleId IdType="pubmed">22020137</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Heeswijk R.P.G., Dannemann B., Hoetelmans R.M.W. Bedaquiline: A review of human pharmacokinetics and drug&#x2013;drug interactions. J. Antimicrob. Chemother. 2014;69:2310&#x2013;2318. doi: 10.1093/jac/dku171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dku171</ArticleId><ArticleId IdType="pubmed">24860154</ArticleId></ArticleIdList></Reference><Reference><Citation>Upadhayaya R.S., Shinde P.D., Sayyed A.Y., Kadam S.A., Bawane A.N., Poddar A., Plashkevych O., F&#xf6;ldesi A., Chattopadhyaya J. Synthesis and structure of azole-fused indeno[2,1-c]quinolines and their anti-mycobacterial properties. Org. Biomol. Chem. 2010;8:5661&#x2013;5673. doi: 10.1039/c0ob00445f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c0ob00445f</ArticleId><ArticleId IdType="pubmed">20927480</ArticleId></ArticleIdList></Reference><Reference><Citation>Upadhayaya R.S., Lahore S.V., Sayyed A.Y., Dixit S.S., Shinde P.D., Chattopadhyaya J. Conformationally-constrained indeno[2,1-c]quinolones&#x2014;A new class of anti-mycobacterial agents. Org. Biomol. Chem. 2010;8:2180&#x2013;2197. doi: 10.1039/b924102g.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/b924102g</ArticleId><ArticleId IdType="pubmed">20401395</ArticleId></ArticleIdList></Reference><Reference><Citation>Upadhayaya R.S., Shinde P.D., Kadam S.A., Bawane A.N., Sayyed A.Y., Kardile R.A., Gitay P.N., Lahore S.V., Dixit S.S., F&#xf6;ldesi A., et al. Synthesis and antimycobacterial activity of prodrugs of indeno[2,1-c]quinoline derivatives. Eur. J. Med. Chem. 2011;46:1306&#x2013;1324. doi: 10.1016/j.ejmech.2011.01.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2011.01.053</ArticleId><ArticleId IdType="pubmed">21334792</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheu J.Y., Chen Y.L., Fang K.C., Wang T.C., Tzeng C.C., Peng C.F. Synthesis and antibacterial activity of 1-(substituted-benzyl)-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acids and their 6,8-difluoro analogs. J. Heterocycl. Chem. 1998;35:955&#x2013;964. doi: 10.1002/jhet.5570350429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jhet.5570350429</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheu J.Y., Chen Y.L., Tzeng C.C., Hsu S.L., Fang K.C., Wang T.C. Synthesis, and antimycobacterial and cytotoxic evaluation of certain fluoroquinolone derivatives. Helv. Chim. Acta. 2003;86:2481&#x2013;2489. doi: 10.1002/hlca.200390201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hlca.200390201</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y.L., Chen Y.L., Sheu J.Y., Chen I.L., Wang T.C., Tzeng C.C. Synthesis and antimycobacterial evaluation of certain fluoroquinolone derivatives. Bioorg. Med. Chem. 2005;13:3921&#x2013;3926. doi: 10.1016/j.bmc.2005.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2005.04.005</ArticleId><ArticleId IdType="pubmed">15911308</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.L., Huang H.Y., Chen Y.W., Huang Z.Y., Tzeng C.C., Liu C.L., Yao C.W. Synthesis and antimycobacterial evaluation of metal-chelator bearing fluoroquinolones. Chin. Pharm. J. 2005;57:57&#x2013;70.</Citation></Reference><Reference><Citation>Yang C.L., Tseng C.H., Chen Y.L., Lu C.M., Kao C.L., Tseng H.Y., Wu M.H., Tzeng C.C. Identification of benzofuro[2,3-b]quinoline derivatives as a new class of antituberculosis agents. Eur. J. Med. Chem. 2010;45:602&#x2013;607. doi: 10.1016/j.ejmech.2009.10.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2009.10.050</ArticleId><ArticleId IdType="pubmed">19926361</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.L., Lu C.M., Chen I.L., Tsao L.T., Wang J.P. Synthesis and antiinflammatory evaluation of 9-anilinoacridine and 9-phenoxyacridine derivatives. J. Med. Chem. 2002;45:4689&#x2013;4694. doi: 10.1021/jm020102v.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm020102v</ArticleId><ArticleId IdType="pubmed">12361395</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.L., Chen I.L., Lu C.M., Tzeng C.C., Tsao L.T., Wang J.P. Synthesis and anti-inflammatory evaluation of 9-phenoxyacridine and 4-phenoxyfuro[2,3-b]quinoline derivatives. Part 2. Bioorg. Med. Chem. 2003;11:3921&#x2013;3927. doi: 10.1016/S0968-0896(03)00439-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0968-0896(03)00439-5</ArticleId><ArticleId IdType="pubmed">12927852</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.L., Chen I.L., Lu C.M., Tzeng C.C., Tsao L.T., Wang J.P. Synthesis and anti-inflammatory evaluation of 4-anilinofuro[2,3-b]quinoline and 4-phenoxyfuro[2,3-b]quinoline derivatives. Part 3. Bioorg. Med. Chem. 2004;12:387&#x2013;392. doi: 10.1016/j.bmc.2003.10.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2003.10.051</ArticleId><ArticleId IdType="pubmed">14723957</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuan Y.H., Lin R.H., Chen Y.L., Tsao L.T., Tzeng C.C., Wang J.P. Effective attenuation of acute lung injury in vivo and the formyl peptide-induced neutrophil activation in vitro by CYL-26z through the phosphoinositide 3-kinase gamma pathway. Biochem. Pharmacol. 2006;72:749&#x2013;760. doi: 10.1016/j.bcp.2006.06.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2006.06.025</ArticleId><ArticleId IdType="pubmed">16887102</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.L., Zhao Y.L., Lu C.M., Tzeng C.C., Wang J.P. Synthesis, cytotoxicity, and anti-inflammatory evaluation of 2-(furan-2-yl)-4-(phenoxy)quinoline derivatives, Part 4. Bioorg. Med. Chem. 2006;14:4373&#x2013;4378. doi: 10.1016/j.bmc.2006.02.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2006.02.039</ArticleId><ArticleId IdType="pubmed">16524734</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M.W., Tsao L.T., Chang L.C., Chen Y.L., Huang L.J., Kuo S.C., Tzeng C.C., Lee M.R., Wang J.P. Inhibition of lipopolysaccharide-stimulated NO production by a novel synthetic compound CYL-4d in RAW 264.7 macrophages involving the blockade of MEK4/JNK/AP-1 pathway. Biochem. Pharmacol. 2007;73:1796&#x2013;1806. doi: 10.1016/j.bcp.2007.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2007.02.009</ArticleId><ArticleId IdType="pubmed">17379190</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng C.H., Lin C.S., Shih P.K., Tsao L.T., Wang J.P., Cheng C.M., Tzeng C.C., Chen Y.L. Furo[3, 2:3,4]naphtho[1,2-d]imidazole derivatives as potential inhibitors of inflammatory factors in sepsis. Bioorg. Med. Chem. 2009;17:6773&#x2013;6779. doi: 10.1016/j.bmc.2009.07.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2009.07.054</ArticleId><ArticleId IdType="pubmed">19699097</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng C.H., Tzeng C.C., Shih P.K., Yang C.N., Chuang Y.C., Peng S.I., Lin C.S., Wang J.P., Cheng C.M., Chen Y.L. Identification of furo[3&#x2032;,2&#x2032;:3,4]naphtho[1,2-d]imidazole derivatives as orally active and selective inhibitors of microsomal prostaglandin E(2) synthase-1 (mPGES-1) Mol. Divers. 2012;16:215&#x2013;229. doi: 10.1007/s11030-011-9347-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11030-011-9347-9</ArticleId><ArticleId IdType="pubmed">22161217</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai Y.R., Huang L.J., Lee M.R., Chen Y.L., Kuo S.C., Tzeng C.C., Hsu M.F., Wang J.P. The signaling mechanisms mediating the inhibitory effect of TCH-1116 on formyl peptide-stimulated superoxide anion generation in neutrophils. Eur. J. Pharm. 2012;682:171&#x2013;180. doi: 10.1016/j.ejphar.2012.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2012.02.016</ArticleId><ArticleId IdType="pubmed">22510297</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng C.H., Cheng C.M., Tzeng C.C., Peng S.I., Yang C.L., Chen Y.L. Synthesis and anti-inflammatory evaluations of &#xe2;-lapachone derivatives. Bioorg. Med. Chem. 2013;21:523&#x2013;531. doi: 10.1016/j.bmc.2012.10.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2012.10.047</ArticleId><ArticleId IdType="pubmed">23232148</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.R., Tseng C.H., Chen Y.L., Hwang T.L., Tzeng C.C. Discovery of benzo[f]indole-4,9-dione derivatives as new type of anti-inflammatory agents. Int. J. Mol. Sci. 2015;16:6532&#x2013;6544. doi: 10.3390/ijms16036532.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms16036532</ArticleId><ArticleId IdType="pmc">PMC4394546</ArticleId><ArticleId IdType="pubmed">25807261</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng C.H., Chen Y.L., Lu P.J., Yang C.N., Tzeng C.C. Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives. Bioorg. Med. Chem. 2008;16:3153&#x2013;3162. doi: 10.1016/j.bmc.2007.12.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2007.12.028</ArticleId><ArticleId IdType="pubmed">18180162</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung C.W. Prediction of pupylation sites using the composition of k-spaced amino acid pairs. J. Theor. Biol. 2013;336:11&#x2013;17. doi: 10.1016/j.jtbi.2013.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtbi.2013.07.009</ArticleId><ArticleId IdType="pubmed">23871866</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung C.W., Wu M.T., Chen Y.K., Wu C.C., Chen W.C., Li H.P., Chou S.H., Wu D.C., Wu I.C. Identification of biomarkers for esophageal squamous cell carcinoma using feature selection and decision tree methods. Sci. World J. 2013;2013:782031. doi: 10.1155/2013/782031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/782031</ArticleId><ArticleId IdType="pmc">PMC3875100</ArticleId><ArticleId IdType="pubmed">24396308</ArticleId></ArticleIdList></Reference><Reference><Citation>Kier L.B., Hall L.H. Molecular Connectivity in Chemistry and Drug Research. Academic Press; New York, NY, USA: 1976.</Citation></Reference><Reference><Citation>Wildman S.A., Crippen G.M. Prediction of physicochemical parameters by atomic contributions. J. Chem. Inf. Comput. Sci. 1999;39:868&#x2013;873. doi: 10.1021/ci990307l.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci990307l</ArticleId></ArticleIdList></Reference><Reference><Citation>Gramatica P., Corradi M., Consonni V. Modelling and prediction of soil sorption coefficients of non-ionic organic pesticides by molecular descriptors. Chemosphere. 2000;41:763&#x2013;777. doi: 10.1016/S0045-6535(99)00463-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0045-6535(99)00463-4</ArticleId><ArticleId IdType="pubmed">10834380</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall L.H., Kier L.B. Electrotopological state indices for atom types: A novel combination of electronic, topological, and valence state information. J. Chem. Inf. Comput. Sci. 1995;35:1039&#x2013;1045. doi: 10.1021/ci00028a014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci00028a014</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R., Sun H., So S.S. Development of quantitative structure&#x2014;Property relationship models for early ADME evaluation in drug discovery. 2. Blood-brain barrier penetration. J. Chem. Inf. Comput. Sci. 2001;41:1623&#x2013;1632. doi: 10.1021/ci010290i.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci010290i</ArticleId><ArticleId IdType="pubmed">11749589</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins L., Franzblau S.G. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob. Agents Chemother. 1997;41:1004&#x2013;1009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC163841</ArticleId><ArticleId IdType="pubmed">9145860</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang T.L., Li G.L., Lan Y.H., Chia Y.C., Hsieh P.W., Wu Y.H., Wu Y.C. Potent inhibition of superoxide anion production in activated human neutrophils by isopedicin, a bioactive component of the chinese medicinal herb Fissistigma oldhamii. Free Radic. Biol. Med. 2009;46:520&#x2013;528. doi: 10.1016/j.freeradbiomed.2008.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2008.11.014</ArticleId><ArticleId IdType="pubmed">19100830</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap C.W. PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints. J. Comput. Chem. 2011;32:1466&#x2013;1474. doi: 10.1002/jcc.21707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.21707</ArticleId><ArticleId IdType="pubmed">21425294</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbeck C., Han Y., Kuhn S., Horlacher O., Luttmann E., Willighage E. The Chemistry Development Kit (CDK): An open-source Java library for Chemo- and Bioinformatics. J. Chem. Inf. Comput. Sci. 2003;43:493&#x2013;500. doi: 10.1021/ci025584y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci025584y</ArticleId><ArticleId IdType="pmc">PMC4901983</ArticleId><ArticleId IdType="pubmed">12653513</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung C.W., Jheng J.L. Interpretable prediction of non-genotoxic hepatocarcinogenic chemicals. Neurocomputing. 2014;145:68&#x2013;74. doi: 10.1016/j.neucom.2014.05.073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neucom.2014.05.073</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauhan J.S., Dhanda S.K., Singla D., The Open Source Drug Discovery. Agarwal S.M., Raghava G.P.S. QSAR-based models for designing quinazoline/imidazothiazoles/pyrazolopyrimidines based inhibitors against wild and mutant EGFR. PLoS ONE. 2014;9:e101079. doi: 10.1371/journal.pone.0101079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0101079</ArticleId><ArticleId IdType="pmc">PMC4081576</ArticleId><ArticleId IdType="pubmed">24992720</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>